Dealing in Securities by an Associate of a Director
Shoprite Holdings Limited
(Incorporated in the Republic of South Africa)
Registration no. 1936/007721/06
ISIN: ZAE000012084
JSE share code: SHP
A2X share code: SHP
NSX share code: SRH
LuSE share code: SHOPRITE
("Shoprite Holdings")
DEALING IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR
Shareholders are referred to the announcement released on SENS on 18 October 2023 in respect of a scrip
borrow arrangement in terms of which Titan Fincap Solutions (RF) (Pty) Limited ("Titan Fincap") borrowed
3,831,164 Shoprite Holdings ordinary shares ("Scrip Loan") on 12 October 2023 ("Initial Announcement").
Titan Fincap has subsequently acquired Shoprite Holdings ordinary shares to settle the Scrip Loan, details of
which are set out in the table below.
Shareholders are further advised that the intergroup options between associates of Dr CH Wiese (Titan
Premier Investments (Pty) Limited ("TPI"), Thibault Square Financial Services (Pty) Limited ("Thibault") and
Titan Fincap) as described in the Initial Announcement still remain in place.
Name of director: Dr CH Wiese
Designation: Non-executive Director
Name of associate Titan Fincap
Date of transaction: 7 October 2024
Class of securities: Ordinary shares
Nature of transaction: On-market purchase of ordinary shares and
settlement of Scrip Loan by Titan Fincap (on
market)
Price per ordinary share: R290
Number of ordinary shares: 3,831,164
Value of the transaction: R1,111,037,560
Nature of interest for director: Indirect beneficial through Titan Fincap controlled
by TPI, of which Dr CH Wiese is a director
Nature of interest for associate: Direct beneficial
Written clearance to deal received: Yes
In addition, Titan Fincap sold a total return swap, with a reference price of R290 per Shoprite Holdings ordinary
share, which will be settled in cash.
Name of director: Dr CH Wiese
Designation: Non-executive Director
Name of associate: Titan Fincap
Date of transaction: 7 October 2024
Termination Date 8 October 2024
Class of securities: Ordinary shares
Nature of transaction: Total return swap (off-market)
Deemed price per ordinary share: R290 (based on the acquisition price of Shoprite
Holdings ordinary shares used to settle the Scrip
Loan)
Number of ordinary shares: 3,831,164
Value of the transaction: R1,111,037,560
Nature of interest for director: Indirect beneficial through Titan Fincap controlled
by TPI, of which Dr CH Wiese is a director
Nature of interest for associate: Direct beneficial
Written clearance to deal received: Yes
The above transactions, prior to the exercise of the intra-group options (as outlined in the Initial
Announcement), do not affect any of the voting rights in respect of Shoprite Holdings ordinary shares and
deferred shares held by Thibault.
Cape Town
10 October 2024
Sponsor
Nedbank Corporate and Investment Banking, a division of Nedbank Limited
Date: 10-10-2024 10:37:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.